Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1
dc.contributor.author | Fantone, Joseph C. | en_US |
dc.contributor.author | Kunkel, Steven L. | en_US |
dc.contributor.author | Ward, Peter A. | en_US |
dc.contributor.author | Zurier, Robert B. | en_US |
dc.date.accessioned | 2006-04-07T18:03:12Z | |
dc.date.available | 2006-04-07T18:03:12Z | |
dc.date.issued | 1981-08 | en_US |
dc.identifier.citation | Fantone, Joseph C., Kunkel, Steven L., Ward, Peter A., Zurier, Robert B. (1981/08)."Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1." Prostaglandines and Medicine 7(2): 195-198. <http://hdl.handle.net/2027.42/24290> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B7GHB-4C35N4P-2J/2/02b66d75417b4b8630e8ab8034b2199d | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24290 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7197036&dopt=citation | en_US |
dc.description.abstract | In two of three patients with peripheral vascular disease, systemic infusion of PGE1 inhibited chemotactic factor induced secretion of glucosaminidase from neutrophils. | en_US |
dc.format.extent | 275394 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Dept. of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Dept. of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Dept. of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationother | Rheumatology Section, Hospital of the University of Pennsylvania, Philadelhia, PA 19104, USA | en_US |
dc.identifier.pmid | 7197036 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24290/1/0000556.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0161-4630(81)90062-8 | en_US |
dc.identifier.source | Prostaglandines and Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.